Cancer Family
Breast Neoplasm
CI-CAN-00000007Explore in graph →
Non-malignant2,895 active trials43 approved drugs310 evidence items
- NCIt
- C2910
- OncoTree
- BNNOS
- MeSH
- D000069584
- MeSH
- D001943
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000007Explore in graph →
Clinical trials
13,871 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07313397 | Self-management Interventions to Reduce Cardiovascular Risks in Breast Cancer Survivors | not yet recruiting | N/A | 15 | University of Southern QueenslandOTHER | 1 | May 19, 2026 | clinicaltrials |
| NCT07596472 | Ultrasound Monitoring of Clipped Lymph Nodes to Predict Axillary Response After Chemotherapy in Breast Cancer | not yet recruiting | — | 150 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | May 19, 2026 |
| clinicaltrials |
| NCT07593196 | HER2-positive Metastatic Breast Cancer in Kazakhstan | not yet recruiting | — | 240 | AstraZenecaINDUSTRY | 1 | May 18, 2026 | clinicaltrials |
| NCT07593365 | Clinical Application of Vagus Nerve Stimulation Combined With Immunoregulatory T Cells in Alleviating Aromatase Inhibitor-Induced Pain | not yet recruiting | N/A | 216 | Peking University People's HospitalOTHER | 1 | May 18, 2026 | clinicaltrials |
| NCT07593651 | EXpander-based Versus Direct to Implant PRE-pectoral Breast Reconstruction: a Comparative Analysis of Surgical Outcomes(EXPRESSO) | not yet recruiting | — | 276 | IRCCS San RaffaeleOTHER | 0 | May 18, 2026 | clinicaltrials |
| NCT07593846 | The Comparison Between DEDTI BR and T/E BR(DETE-BR) | not yet recruiting | Phase 3 | 412 | West China HospitalOTHER | 1 | May 18, 2026 | clinicaltrials |
| NCT07593911 | A Study to Evaluate MTM-H-001 Injection in Adult Patients With B-Cell-Related Autoimmune Diseases(ArchAid-002) | not yet recruiting | N/A | 75 | Beijing GoBroad HospitalOTHER | 1 | May 18, 2026 | clinicaltrials |
| NCT07583134 | Impact of Propranolol Strategies on Myocardial Injury After Breast Cancer Surgery(B-BIT) | not yet recruiting | Phase 4 | 100 | Chang-Ik YoonOTHER | 1 | May 15, 2026 | clinicaltrials |
| NCT07589101 | 5T4 Targeting Nanobody Probe for PET Imaging in Solid Tumors | not yet recruiting | N/A | 20 | Peking University Cancer Hospital & InstituteOTHER | 1 | May 15, 2026 | clinicaltrials |
| NCT07589699 | Trastuzumab Rezetecan (T-DXh) in HER2+ Breast Cancer With Non-pCR After TCbHP | not yet recruiting | Phase 4 | 59 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 0 | May 15, 2026 | clinicaltrials |
| NCT07590583 | Biology Guided Therapy Recommendations for Treatment Determination of Hormone Receptor-Positive Advanced, Unresectable or Metastatic Breast Cancer, ENDORSE Trial | not yet recruiting | Phase 1 | 20 | City of Hope Medical CenterOTHER | 1 | May 15, 2026 | clinicaltrials |
| NCT07591532 | Pregnancy Outcomes After Breast Cancer in Young Women With Germline Pathogenic Variants in Genes Other Than BRCA(Beyond BCY) | not yet recruiting | — | 2,200 | Jules Bordet InstituteOTHER | 0 | May 15, 2026 | clinicaltrials |
| NCT07583719 | Effects of Moderate-intensity Interval Aerobic Exercise (MIIAE) on Inflammatory, Immune, Metabolic, Physical Fitness, and Quality of Life Parameters in Breast Cancer Patients Undergoing Radiotherapy. | not yet recruiting | N/A | 40 | Universidad Francisco de VitoriaOTHER | 0 | May 13, 2026 | clinicaltrials |
| NCT07580833 | A Study to Investigate the Effect of Food on the Bioavailability of Oral Paclitaxel Administered With Encequidar in Participants With Advanced Solid Tumors | not yet recruiting | Phase 1 | 46 | Health Hope PharmaINDUSTRY | 0 | May 12, 2026 | clinicaltrials |
| NCT07581795 | Study of Paclitaxel Polymeric Micelles Combined With HP and Adebelimab Versus Taxane Combined With HP as First-Line Treatment for Advanced HER2-Positive Breast Cancer(SPECTACLE) | not yet recruiting | Phase 2 | 140 | Fudan UniversityOTHER | 1 | May 12, 2026 | clinicaltrials |
| NCT07449273 | Breathing Interventions for Postoperative Breast Surgery Patients(BREATH-RCT) | not yet recruiting | N/A | 126 | Ondokuz Mayıs UniversityOTHER | 0 | May 11, 2026 | clinicaltrials |
| NCT07536867 | Comparison of Serratus Posterior Superior Intercostal Plane Block and Rhomboid Intercostal Block in Patients Undergoing Breast Cancer Surgery(SPSIP-RIB) | not yet recruiting | N/A | 60 | Antalya City HospitalOTHER | 1 | May 11, 2026 | clinicaltrials |
| NCT07578415 | Shared Decision Making for Patients With HER2-negative Metastatic Breast Cancer (SDM-01)(SDM-01) | not yet recruiting | N/A | 120 | Federico II UniversityOTHER | 0 | May 11, 2026 | clinicaltrials |
| NCT07575386 | The Effect of Video-Assisted Mindfulness-Based Breathing on Quality of Life and Mental Well-Being in Individuals With Breast Cancer | not yet recruiting | N/A | 50 | Ege UniversityOTHER | 0 | May 8, 2026 | clinicaltrials |
| NCT07573657 | Ultrasound-Guided Core Needle Biopsy to Assess Sensitivity and Specificity of Axillary Lymph Node Metastasis in Breast Cancer | not yet recruiting | — | 200 | The First Hospital of Jilin UniversityOTHER | 0 | May 7, 2026 | clinicaltrials |
| NCT07570368 | Targeting Stress-Driven Inflammatory and Angiogenic Pathways With Brief ACT to Enhance Neoadjuvant Chemotherapy Response in Locally Advanced Breast Cancer | not yet recruiting | N/A | 54 | Universitas AirlanggaOTHER | 0 | May 6, 2026 | clinicaltrials |
| NCT07565324 | Phase II Study of Ultrasound and ctDNA Guided Neoadjuvant Systemic Therapy for Patients With HER2-positive Early Breast Cancer (UC HER Trial)(UC HER) | not yet recruiting | Phase 2 | 54 | National Taiwan University HospitalOTHER | 1 | May 4, 2026 | clinicaltrials |
| NCT07285993 | Detection and Outcomes in Metastatic Invasive Lobular Breast Cancer Through Novel F-18 FAP PET | not yet recruiting | Phase 2 | 15 | Randy YehOTHER | 1 | May 1, 2026 | clinicaltrials |
| NCT07562789 | Role of PCGEM1 in Breast Cancer | not yet recruiting | — | 90 | Assiut UniversityOTHER | 0 | May 1, 2026 | clinicaltrials |
| NCT07562945 | Effect of Continuous Erector Spinae Plane Block With Ropivacaine on Postoperative Pain and NF-κB Levels After Mastectomy | not yet recruiting | N/A | 40 | Aldy AldyOTHER | 1 | May 1, 2026 | clinicaltrials |
| NCT07497256 | Decision Aid for Women Newly Diagnosed With Breast Cancer(BCT Aid) | not yet recruiting | N/A | 160 | Xiamen UniversityOTHER | 1 | Apr 30, 2026 | clinicaltrials |
| NCT07539753 | Brain Radiotherapy Combined With Dalpiciclib and Endocrine Therapy in HR-Positive/HER2-Negative Advanced Breast Cancer With Brain Metastases | not yet recruiting | Phase 2 | 46 | Nanfang Hospital, Southern Medical UniversityOTHER | 1 | Apr 30, 2026 | clinicaltrials |
| NCT07560124 | A Study of AK138D1 Alone or in Combination With Ivonescimab in Advanced Breast Cancer | not yet recruiting | Phase 1 / Phase 2 | 286 | AkesoINDUSTRY | 1 | Apr 30, 2026 | clinicaltrials |
| NCT07555600 | Enumeration and Functional Analysis of Circulating Tumor Cells for Homologous Recombination: a Prospective Single-center Study on Advanced/Metastatic Solid Tumors(E-FACTOR) | not yet recruiting | N/A | 300 | Centre Leon BerardOTHER | 0 | Apr 29, 2026 | clinicaltrials |
| NCT07554781 | A Single-Center, Retrospective Study to Improve the Visibility of Breast Tissue Marker Clips in Breast Tissue and Axillary Lymph Nodes Using the Color Doppler Twinkling Artifact | not yet recruiting | — | 86 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 0 | Apr 28, 2026 | clinicaltrials |
| NCT07494448 | Phase Ib/II Study of Zanidatamab Plus Tucatinib and Chemotherapy in HER2-Positive Advanced Breast Cancer(JAZMINE) | not yet recruiting | Phase 1 / Phase 2 | 24 | MedSIROTHER | 0 | Apr 23, 2026 | clinicaltrials |
| NCT07544134 | Areola Preservation in NSM With Nipple Involvement(APRESERVE-1) | not yet recruiting | N/A | 40 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Apr 22, 2026 | clinicaltrials |
| NCT07545044 | A Study of JSKN003 Versus Trastuzumab in Combination With Pertuzumab and Docetaxel as First-Line Treatment for HER2-Positive Recurrent or Metastatic Breast Cancer | not yet recruiting | Phase 2 | 60 | Shanghai JMT-Bio Inc.INDUSTRY | 0 | Apr 22, 2026 | clinicaltrials |
| NCT07541859 | Breast and Cervical Cancer Awareness Training in Visually Impaired Women(GORSEM) | not yet recruiting | N/A | 74 | Marmara UniversityOTHER | 1 | Apr 21, 2026 | clinicaltrials |
| NCT07543107 | Verification of Range Accuracy and Correlation With Clinical Toxicity Using Offline PET/CT for Hypofractionated Proton Radiotherapy in Breast Cancer(OFFLINE-PET-PR) | not yet recruiting | — | 30 | Ruijin HospitalOTHER | 0 | Apr 21, 2026 | clinicaltrials |
| NCT07543250 | A Real-World Study of Inavolisib in Patients With HR-Positive/HER2-Negative, PIK3CA-Mutated Advanced Breast Cancer | not yet recruiting | — | 100 | xuliangOTHER | 0 | Apr 21, 2026 | clinicaltrials |
| NCT07015853 | ASTRAEA: ReinvigorAting ReSponse To ImmunotheRApy in MEtAstatic TNBC With Combination Myeloid Inhibition and Radiation | not yet recruiting | Phase 2 | 34 | Stephen ShiaoOTHER | 1 | Apr 20, 2026 | clinicaltrials |
| NCT07539545 | The Comparison Between M-E-BCS and C-O-BCS.(MECO) | not yet recruiting | N/A | 1,366 | Du ZhengguiOTHER | 1 | Apr 20, 2026 | clinicaltrials |
| NCT07540520 | A Real-World Study on the Impact of Different Adjuvant Treatment Regimens on Prognosis in Non-pCR Patients With HER2-Positive Breast Cancer After Neoadjuvant Therapy | not yet recruiting | — | 2,000 | Hebei Medical University Fourth HospitalOTHER | 0 | Apr 20, 2026 | clinicaltrials |
| NCT07504770 | Surgical Glove Compression to Prevent Paclitaxel Neuropathy(Surgical Glove) | not yet recruiting | N/A | 84 | Necmettin Erbakan UniversityOTHER | 1 | Apr 17, 2026 | clinicaltrials |
| NCT07527806 | Optimization of Dynamic Neoadjuvant Therapy Strategies for HER2-Positive Breast Cancer Based on HER2-PET/CT Molecular Imaging | not yet recruiting | Phase 2 | 156 | Peking University Cancer Hospital & InstituteOTHER | 0 | Apr 17, 2026 | clinicaltrials |
| NCT07537712 | Proton vs Photon IMRT Toxicity in Breast Cancer(PPTOX-BC) | not yet recruiting | — | 750 | Ruijin HospitalOTHER | 1 | Apr 17, 2026 | clinicaltrials |
| NCT07425548 | Evaluation of Quality of Life After Facial Hyaluroic Acid Injections Following Treatment for Breast Cancer.(JOUVENCE) | not yet recruiting | N/A | 22 | Institut BergoniéOTHER | 0 | Apr 16, 2026 | clinicaltrials |
| NCT07533526 | Effects of Instrument-Assisted Constant-Speed Injection Versus Manual Injection on Pain From Large-Volume Subcutaneous Injection of Pertuzumab and Trastuzumab in Breast Cancer: A Randomized, Self-Controlled Study | not yet recruiting | N/A | 40 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Apr 16, 2026 | clinicaltrials |
| NCT07532096 | Extended Sentinel Lymph Node Biopsy With Methylene Blue Single Tracer Post-Neoadjuvant Therapy for Node-Positive Breast Cancer | not yet recruiting | N/A | 240 | Xijing HospitalOTHER | 1 | Apr 15, 2026 | clinicaltrials |
| NCT07527468 | HISMAR: Intraoperative Margin Assessment Using the Histolog® Scanner to Reduce Reoperation in Breast-Conserving Surgery(HISMAR) | not yet recruiting | N/A | 228 | Hôpital du ValaisOTHER | 1 | Apr 14, 2026 | clinicaltrials |
| NCT07527819 | Evaluating Ovarian Toxicity Outcomes Following Immunotherapy in Patients With Triple-Negative Breast Cancer (TNBC)(FERTILE) | not yet recruiting | — | 75 | Peter MacCallum Cancer Centre, AustraliaOTHER | 1 | Apr 14, 2026 | clinicaltrials |
| NCT07528898 | Neoadjuvant SHR-A1811 Combined With Pertuzumab in HER2-Positive Breast Cancer: An Exploratory Clinical Study. | not yet recruiting | Phase 2 | 100 | Hebei Medical University Fourth HospitalOTHER | 1 | Apr 14, 2026 | clinicaltrials |
| NCT02802423 | Phase I/II, Evaluate the Safety and Efficacy of BLEX 404 With Docetaxel in Patients With Advanced/Metastatic Triple Negative Breast Cancer. | not yet recruiting | Phase 1 / Phase 2 | 44 | BioLite, Inc.INDUSTRY | 0 | Apr 13, 2026 | clinicaltrials |
| NCT07516626 | Patient-Derived Organoids to Functionally Characterize Chemotherapy Resistance in Breast Cancer(BC-PDO) | not yet recruiting | — | 40 | Atlas UniversityOTHER | 1 | Apr 13, 2026 | clinicaltrials |
Data updated 23 days agoSource updated May 19, 2026source: clinicaltrials